Wellington Management Group
ENTA icon

Wellington Management Group’s Enanta Pharmaceuticals ENTA Stock Holding History

Wellington Management Group’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.19M Buy
81,633
+6,673
+9% +$89.7K ﹤0.01% 1716
2026
Q1 		$947K Buy
74,960
+11,741
+19% +$157K ﹤0.01% 1685
2025
Q4 		$997K Buy
+63,219
New +$803K ﹤0.01% 1717
2025
Q1 		– Sell
-51,298
Closed -$295K – 1972
2024
Q4 		$295K Buy
51,298
+16,547
+48% +$159K ﹤0.01% 1878
2024
Q3 		$360K Buy
+34,751
New +$454K ﹤0.01% 1852
2020
Q1 		– Sell
-3,614
Closed -$223K – 1950
2019
Q4 		$223K Buy
+3,614
New +$224K ﹤0.01% 1974
2018
Q4 		– Sell
-13,745
Closed -$1.17M – 2090
2018
Q3 		$1.17M Sell
13,745
-8,130
-37% -$814K ﹤0.01% 1841
2018
Q2 		$2.54M Buy
21,875
+6,539
+43% +$652K ﹤0.01% 1665
2018
Q1 		$1.24M Buy
15,336
+4,115
+37% +$317K ﹤0.01% 1854
2017
Q4 		$658K Buy
+11,221
New +$562K ﹤0.01% 1996
2017
Q2 		– Sell
-33,872
Closed -$1.04M – 2231
2017
Q1 		$1.04M Sell
33,872
-9,006
-21% -$280K ﹤0.01% 1914
2016
Q4 		$1.44M Buy
42,878
+4,921
+13% +$141K ﹤0.01% 1776
2016
Q3 		$1.01M Sell
37,957
-67,985
-64% -$1.58M ﹤0.01% 1837
2016
Q2 		$2.34M Buy
105,942
+22,926
+28% +$600K ﹤0.01% 1568
2016
Q1 		$2.44M Buy
83,016
+51,880
+167% +$1.44M ﹤0.01% 1552
2015
Q4 		$1.03M Buy
+31,136
New +$1.01M ﹤0.01% 1824
2015
Q2 		– Sell
-33,973
Closed -$1.04M – 2160
2015
Q1 		$1.04M Buy
33,973
+25,873
+319% +$1.01M ﹤0.01% 1844
2014
Q4 		$412K Buy
+8,100
New +$363K ﹤0.01% 2035
2013
Q4 		– Sell
-324,291
Closed -$7.43M – 2167
2013
Q3 		$7.43M Sell
324,291
-14,500
-4% -$277K ﹤0.01% 1301
2013
Q2 		$6M Buy
+338,791
New +$6.61M ﹤0.01% 1373

Other funds holding ENTA

JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KAM
Krensavage Asset Management New York $263M AUM 66.99% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SSC
Spruce Street Capital New York $510M AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Wellington Management Group's ENTA Position: Q2 2026 in Review

Wellington Management Group increased its Enanta Pharmaceuticals (ENTA) stake by 8.9% in Q2 2026, buying an estimated $89.7K and bringing the position to 81,633 shares worth $1.19M. The position accounts for ﹤0.01% of the portfolio, ranked #1716.

Wellington Management Group first reported a position in ENTA in Q2 2013 and has held it in 20 quarters since. The position peaked at $7.43M in Q3 2013. 123 funds tracked by Wall St. Rank hold ENTA as of Q2 2026.

  • Wellington Management Group held 81,633 shares of Enanta Pharmaceuticals worth $1.19M as of Q2 2026.
  • Wellington Management Group bought 6,673 Enanta Pharmaceuticals shares in Q2 2026, an estimated $89.7K.
  • Enanta Pharmaceuticals made up ﹤0.01% of Wellington Management Group's portfolio in Q2 2026, its #1716 holding.
  • Wellington Management Group first reported a position in Enanta Pharmaceuticals in Q2 2013 and has held it in 20 quarters since.
  • Wellington Management Group's Enanta Pharmaceuticals position peaked at $7.43M in Q3 2013.
  • 123 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q2 2026.

Based on Wellington Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.